secwatch / observer
8-K filed May 4, 2023, 7:59 PM ET ticker LH CIK 0000920148
leadership confidence high sentiment neutral materiality 0.55

Labcorp promotes Mark Schroeder to President Diagnostics & COO; salary $650K plus equity

LABCORP HOLDINGS INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Mark S. Schroeder

Executive Vice President, President Diagnostics & Chief Operations Officer
LH · LABCORP HOLDINGS INC.
Effective
2023-05-01
Filed
May 4, 2023, 7:59 PM ET
Mark S. Schroeder, the current Executive Vice President, and President, Diagnostics Laboratory Operations and Global Supply Chain of Labcorp, a named executive officer, has been appointed to the position of Executive Vice President, President Diagnostics & Chief Operations Officer, effective May 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Mark S. Schroeder was appointed as Executive Vice President, President Diagnostics & Chief Operations Officer at LABCORP HOLDINGS INC..

Action
appointed
Role
Executive Vice President, President Diagnostics & Chief Operations Officer
Exact text from the filing
Mark S. Schroeder, the current Executive Vice President, and President, Diagnostics Laboratory Operations and Global Supply Chain of Labcorp, a named executive officer, has been appointed to the position of Executive Vice President, President Diagnostics & Chief Operations Officer, effective May 1, 2023.
View on SEC.gov

LABCORP HOLDINGS INC. filing history →

Source: SEC EDGAR
accession 0000920148-23-000031
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.